MYO Logo

Myomo, Inc. (MYO) 

AMEX
Market Cap
$126.04M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
140 of 776
Rank in Industry
18 of 100

Largest Insider Buys in Sector

MYO Stock Price History Chart

MYO Stock Performance

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal …

Insider Activity of Myomo, Inc.

Over the last 12 months, insiders at Myomo, Inc. have bought $505,000 and sold $300,405 worth of Myomo, Inc. stock.

On average, over the past 5 years, insiders at Myomo, Inc. have bought $258,442 and sold $134,625 worth of stock each year.

Highest buying activity among insiders over the last 12 months: KIRK THOMAS F (director) — $505,000.

The last purchase of 50,000 shares for transaction amount of $175,000 was made by KIRK THOMAS F (director) on 2024‑05‑29.

List of Insider Buy and Sell Transactions, Myomo, Inc.

2024-09-05SaleChief Medical Officer
6,700
0.0221%
$3.76$25,183+3.18%
2024-09-03SaleChief Medical Officer
2,029
0.0069%
$4.01$8,140-0.26%
2024-05-29Purchasedirector
50,000
0.174%
$3.50$175,000+11.53%
2024-05-15SaleChief Medical Officer
35,426
0.1201%
$3.69$130,839+2.12%
2024-03-14Purchasedirector
50,000
0.1683%
$3.50$175,000+9.01%
2023-12-08Saledirector
14,997
0.0571%
$4.08$61,188-7.18%
2023-12-01SaleChief Medical Officer
8,333
0.0296%
$3.12$26,016+13.21%
2023-11-28Saledirector
14,997
0.0574%
$3.27$49,040+16.98%
2023-11-20Purchasedirector
50,000
0.1929%
$3.10$155,000+23.23%
2023-09-08Purchasedirector
15,000
0.0565%
$1.06$15,867+224.53%
2023-08-30PurchaseChief Executive Officer
48,400
0.2365%
$0.74$36,039+360.81%
2023-08-29PurchaseChief Executive Officer
37,000
0.1804%
$0.78$28,797+332.74%
2023-08-29PurchaseChief Financial Officer
41,666
0.1566%
$0.60$25,000+332.74%
2023-08-29PurchaseChief Medical Officer
8,333
0.0313%
$0.60$5,000+332.74%
2023-08-28PurchaseChief Executive Officer
42,500
0.1883%
$0.75$31,794+325.63%
2023-01-17PurchaseChief Executive Officer
307,692
0.9391%
$0.33$100,000+66.02%
2023-01-17PurchaseChief Financial Officer
76,923
0.2348%
$0.33$25,000+66.02%
2023-01-17PurchaseChief Commerical Officer
15,384
0.047%
$0.33$5,000+66.02%
2022-11-22PurchaseChief Financial Officer
9,000
0.1177%
$0.55$4,960+12.54%
2022-08-05Sale
7,141
0.1017%
$1.71$12,218-60.94%

Insider Historical Profitability

<0.0001%
KIRK THOMAS Fdirector
236499
0.7824%
$4.1750<0.0001%
Kovelman HarryChief Medical Officer
123556
0.4088%
$4.1714
GUDONIS PAUL RChief Executive Officer
878245
2.9056%
$4.1790<0.0001%
HENRY DAVID AChief Financial Officer
352193
1.1652%
$4.1750<0.0001%
SANGHI STEVEdirector
298513
0.9876%
$4.1710

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Aigh Capital Management Llc$9.16M9.732.8M+5.03%+$439,167.555.24
Herr Investment Group Llc$5.38M5.711.65M+67.86%+$2.18M1.74
The Vanguard Group$3.81M4.051.17M-4.22%-$168,198.98<0.0001
ESSEX INVESTMENT MANAGEMENT CO LLC$1.97M2.09602,744+537.86%+$1.66M0.4
Renaissance Technologies$921,000.000.98281,700+45.51%+$288,037.27<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.